Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
Envista
NVST
$3.77B
| $2.03M | ﹤0.01% |
104,075
-14,151
| -12% | -$246K |
2022 Q1
13 quarters
|
|
2802
Astrana Health
ASTH
$1.78B
| $2.03M | ﹤0.01% |
81,676
+23,767
| +41% | +$669K |
2018 Q2
28 quarters
|
|
|
AEVA
2803
Aeva Technologies
AEVA
$1.03B
| $2.03M | ﹤0.01% |
53,718
+30,434
| +131% | +$463K |
2022 Q1
13 quarters
|
|
2804
Harmonic Inc
HLIT
$1.22B
| $2.02M | ﹤0.01% |
213,803
+64,419
| +43% | +$588K |
2013 Q2
48 quarters
|
|
2805
Cullinan Oncology
CGEM
$998M
| $2.02M | ﹤0.01% |
268,467
+27,124
| +11% | +$218K |
2022 Q1
13 quarters
|
|
2806
Bloomin' Brands
BLMN
$726M
| $2.02M | ﹤0.01% |
234,505
+123,690
| +112% | +$993K |
2013 Q2
48 quarters
|
|
2807
Enact Holdings
ACT
$6.22B
| $2.01M | ﹤0.01% |
54,126
+18,757
| +53% | +$666K |
2022 Q1
13 quarters
|
|
2808
Arcus Biosciences
RCUS
$3.11B
| $2.01M | ﹤0.01% |
246,670
+63,939
| +35% | +$546K |
2018 Q2
28 quarters
|
|
2809
Dream Finders Homes
DFH
$973M
| $2.01M | ﹤0.01% |
79,836
-7,718
| -9% | -$173K |
2023 Q4
6 quarters
|
|
|
SA
2810
Seabridge Gold
SA
$2.91B
| $2M | ﹤0.01% |
138,066
-24,346
| -15% | -$309K |
2023 Q2
8 quarters
|
|
2811
Cerus
CERS
$459M
| $2M | ﹤0.01% |
1,421,220
+30,943
| +2% | +$41.3K |
2013 Q2
48 quarters
|
|
|
OLO
2812
DELISTED
Olo Inc
OLO
| $2M | ﹤0.01% |
224,436
+71,152
| +46% | +$552K |
2022 Q1
13 quarters
|
|
|
GLDD
2813
DELISTED
Great Lakes Dredge & Dock
GLDD
| $2M | ﹤0.01% |
163,794
+74,063
| +83% | +$770K |
2016 Q4
34 quarters
|
|
2814
Neogen
NEOG
$2.65B
| $1.99M | ﹤0.01% |
416,899
+114,088
| +38% | +$655K |
2016 Q2
36 quarters
|
|
2815
Porch Group
PRCH
$1.97B
| $1.99M | ﹤0.01% |
168,858
+54,848
| +48% | +$471K |
2022 Q1
13 quarters
|
|
2816
CALL
NIO
NIO
$8.44B
| $1.99M | ﹤0.01% |
+580,000
| New | +$2.16M |
2025 Q2
0 quarters
|
|
2817
Nuvation Bio
NUVB
$1.8B
| $1.99M | ﹤0.01% |
1,019,565
-330,198
| -24% | -$688K |
2022 Q1
13 quarters
|
|
2818
Byline Bancorp
BY
$1.71B
| $1.99M | ﹤0.01% |
74,319
+30,672
| +70% | +$787K |
2017 Q3
31 quarters
|
|
2819
Pennant Group
PNTG
$1.37B
| $1.98M | ﹤0.01% |
66,407
+21,353
| +47% | +$586K |
2022 Q1
13 quarters
|
|
2820
Red Cat Holdings
RCAT
$977M
| $1.98M | ﹤0.01% |
272,185
+207,536
| +321% | +$1.35M |
2024 Q3
3 quarters
|
|
2821
Xeris Biopharma Holdings
XERS
$1.66B
| $1.98M | ﹤0.01% |
424,248
+143,613
| +51% | +$658K |
2022 Q1
13 quarters
|
|
2822
CALL
Dick's Sporting Goods
DKS
$13.4B
| $1.98M | ﹤0.01% |
10,000
-10,000
| -50% | -$1.85M |
2023 Q4
6 quarters
|
|
2823
Gogo Inc
GOGO
$286M
| $1.98M | ﹤0.01% |
134,742
+51,236
| +61% | +$521K |
2016 Q2
36 quarters
|
|
2824
Regenxbio
RGNX
$490M
| $1.97M | ﹤0.01% |
239,535
+119,876
| +100% | +$1M |
2016 Q3
35 quarters
|
|
|
ARIS
2825
Aris Mining
ARIS
$3.61B
| $1.97M | ﹤0.01% |
292,638
+258,062
| +746% | +$1.53M |
2023 Q3
7 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.